Identification of osteogenic factor (5) in the KUSA-A1 osteoblasts
KUSA-A1 成骨细胞中成骨因子 (5) 的鉴定
基本信息
- 批准号:11557021
- 负责人:
- 金额:$ 7.68万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
KUSA/A1 cells were originally isolated as cells which induce hematopoiesis in vivo. When cultured in monolayer, the cells were spindle-shaped in the growth phase and after confluence. Extracellular matrix positive for von Kossa stain appeared in cell culture and increased after confluence. Ultrastructurally, the matrix was electron dense and was clearly produced by the cells. We analyzed the cell surface markers on the clonal KUSA/A1 cells by flow cytometry to better characterize these cells. The cells were found to be strongly positive (more than 10-fold greater than the isotype control) for Sca-1, CD44, Ly-6C and CD140, weakly positive for CD29, and negative for c-kit, Flk-1, CD14, CD31, CD34, CD41, CD45, CD49b, CD49d, CD54, CD90, CD102, CD105, CD106, CD144 and Ly-6G. We then analyzed growth curve, ALP activity, in vitro calcification, osteocalcin (bone gla protein) release, and response to PTH, in comparison with MC3T3-E1 cells. KUSA/A1 proliferation, which was measured by DNA content, was equivalent to that of MC3T3-E1 cells. ALP activity of KUSA/A1 cells in growth phase was approximately 10-fold higher than in MC3T3-E1 cells. In vitro calcification, which steadily increased both before and after confluence, was approximately 100-fold higher after the confluent stage in KUSA/A1 cells than in MC3T3-E1 cells. Osteocalcin release into culture media peaked on day 5 in KUSA/A1 cells and was 2 to 3-fold higher than in MC3T3-E1 cells. PTH response, measured as cAMP production, gradually decreased during the culture period in KUSA/A1 cells, but increased in MC3T3-E1 cells. This response to PTH did not require any induction and was independent of culture conditions.
KUSA/A1细胞最初是作为体内诱导造血的细胞分离的。单层培养时,细胞在生长期和汇合后呈梭形。细胞培养中出现vonKossa染色阳性的细胞外基质,汇合后增加。在超微结构上,基质是电子致密的,并且清楚地由细胞产生。我们通过流式细胞术分析了克隆KUSA/A1细胞上的细胞表面标志物,以更好地表征这些细胞。发现细胞对Sca-1、CD 44、Ly-6C和CD 140呈强阳性(比同种型对照高10倍以上),对CD 29呈弱阳性,对c-kit、Flk-1、CD 14、CD 31、CD 34、CD 41、CD 45、CD 49 b、CD 49 d、CD 54、CD 90、CD 102、CD 105、CD 106、CD 144和Ly-6 G呈阴性。以MC 3 T3-E1细胞为对照,分析其生长曲线、ALP活性、体外钙化、骨钙素(骨钙素)释放和对PTH的反应。KUSA/A1细胞的增殖能力与MC 3 T3-E1细胞相当。KUSA/A1细胞在生长期的ALP活性比MC 3 T3-E1细胞高约10倍。在体外钙化,这稳步增加之前和之后的融合,是约100倍以上的融合阶段后,在KUSA/A1细胞比MC 3 T3-E1细胞。在KUSA/A1细胞中,骨钙素释放到培养基中在第5天达到峰值,并且比MC 3 T3-E1细胞高2至3倍。在培养过程中,KUSA/A1细胞的PTH反应(以cAMP的产生来衡量)逐渐下降,而MC 3 T3-E1细胞的PTH反应则逐渐增加。这种对PTH的反应不需要任何诱导,并且与培养条件无关。
项目成果
期刊论文数量(148)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shibata, R.: "Correlation between a specific Wilms tumor suppressor gene (Wt1) mutation and the histological findingz in Wilms tumor (WT)"J. Med. Genet. 39-12. E83 (2002)
Shibata, R.:“特定肾母细胞瘤抑制基因 (Wt1) 突变与肾母细胞瘤 (WT) 组织学发现之间的相关性”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hakuno, D.: "Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors"Circulation. 105. 380-386 (2002)
Hakuno, D.:“骨髓来源的再生心肌细胞(CMG 细胞)表达功能性肾上腺素能和毒蕈碱受体”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
堀内 正嗣: "生活習慣と遺伝子疾患"メディカルレビュー社. 396 (2002)
堀内正史:《生活方式与遗传疾病》医学评论出版 396(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fukuma, M.: "Up-regulation of Id2,an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma"Oncogene. 22. 1-9 (2003)
Fukuma, M.:“Id2(一种致癌螺旋-环-螺旋蛋白)的上调是由尤文肉瘤中的嵌合 EWS/ets 蛋白介导的”癌基因。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Okita et al .: "Acute myeloid leukemia possessing jumping translocation is related to highly elevated levels of EAT/mcl-1, a Bcl-2 related gene with anti-apoptotic functions"Leukemia Res. 24. 73-77 (2000)
H.Okita 等人:“具有跳跃易位的急性髓性白血病与 EAT/mcl-1 水平的高度升高有关,EAT/mcl-1 是一种具有抗凋亡功能的 Bcl-2 相关基因”Leukemia Res.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UMEZAWA Akihiro其他文献
UMEZAWA Akihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UMEZAWA Akihiro', 18)}}的其他基金
Identification of cardiomyogenic factor in terms of cell-based therapy/regenerative medicine
细胞治疗/再生医学中心肌生成因子的鉴定
- 批准号:
22390072 - 财政年份:2010
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of human cells as feeder cells of human embryonic stem cells
建立人类细胞作为人类胚胎干细胞的饲养细胞
- 批准号:
21659092 - 财政年份:2009
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Identification of human cardiomyogenic factor
人类心肌生成因子的鉴定
- 批准号:
18390116 - 财政年份:2006
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The function of the EAT, an inhibitor of apotptosis, in vivo and its molecular mechanism in disease
细胞凋亡抑制剂EAT的体内功能及其在疾病中的分子机制
- 批准号:
13470053 - 财政年份:2001
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Anti-apoptotic function of EAT/mcl-1 on diseases
EAT/mcl-1对疾病的抗凋亡作用
- 批准号:
11670192 - 财政年份:1999
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular diagnosis of pediatric solid tumor
小儿实体瘤的分子诊断
- 批准号:
09670204 - 财政年份:1997
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
骨病多模态报告和数据系统(Bone-RADS):规范精准风险评估并优化诊疗管理建议的临床研究
- 批准号:
- 批准年份:2024
- 资助金额:5.0 万元
- 项目类别:省市级项目
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
- 批准号:82371102
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
- 批准号:82370889
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
- 批准号:82371770
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
- 批准号:82371799
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
槲皮素控释系统调控Mettl3/Per1修复氧化应激损伤促牙周炎骨再生及机制研究
- 批准号:82370921
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
基于AMPK/PGC-1α信号轴的工程化外泌体靶向调控BMSCs能量代谢重编程在老年机体骨修复中的作用及其机制研究
- 批准号:82370920
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
MFB(Main Fractured Bone)概念结合AO分型对桡骨远端骨折的临床诊疗研究
- 批准号:2018JJ4093
- 批准年份:2018
- 资助金额:0.0 万元
- 项目类别:省市级项目
Fgf19对耳蜗毛细胞发育调控机制的研究
- 批准号:31140047
- 批准年份:2011
- 资助金额:10.0 万元
- 项目类别:专项基金项目
骨形态发生蛋白(Bone Morphogenetic Proteins,BMP)信号在脊髓损伤中枢神经性疼痛中的作用
- 批准号:81070994
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Evaluating the role of immunomodulation in synergizing BMP-induced bone repair
评估免疫调节在协同 BMP 诱导的骨修复中的作用
- 批准号:
10728000 - 财政年份:2023
- 资助金额:
$ 7.68万 - 项目类别:
Characterizing the cranial neural crest response to BMP signaling through gastrulation and neurulation
通过原肠胚形成和神经形成表征颅神经嵴对 BMP 信号的反应
- 批准号:
10782064 - 财政年份:2023
- 资助金额:
$ 7.68万 - 项目类别:
Elucidating the structural insights into the BMP receptor mutations in PAH
阐明 PAH 中 BMP 受体突变的结构见解
- 批准号:
10659947 - 财政年份:2023
- 资助金额:
$ 7.68万 - 项目类别:
Multi-Omic Analysis of BMP-Insulin Signaling Crosstalk in Lipid Metabolism during Aging
衰老过程中脂质代谢中 BMP-胰岛素信号串扰的多组学分析
- 批准号:
10351581 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:
Temporal regulation of BMP signaling in patterning the tracheal cartilage and pharmacological approaches to prevent tracheomalacia
BMP 信号在气管软骨模式化中的时间调节和预防气管软化的药理学方法
- 批准号:
10417330 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:
Bone marrow regeneration as an organ by reactivation of the developmental field applying BMP-2
通过应用 BMP-2 重新激活发育场,骨髓再生为器官
- 批准号:
20KK0377 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Multi-Omic Analysis of BMP-Insulin Signaling Crosstalk in Lipid Metabolism during Aging
衰老过程中脂质代谢中 BMP-胰岛素信号串扰的多组学分析
- 批准号:
10553134 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:
Quantitative analysis of signaling dynamics across the BMP morphogen gradient
BMP 形态发生素梯度信号动力学的定量分析
- 批准号:
10627788 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:
Quantitative analysis of signaling dynamics across the BMP morphogen gradient
BMP 形态发生素梯度信号动力学的定量分析
- 批准号:
10386746 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:
Targeting BMP type 2 receptor for the treatment of breast cancer.
靶向 BMP 2 型受体治疗乳腺癌。
- 批准号:
10515890 - 财政年份:2022
- 资助金额:
$ 7.68万 - 项目类别:














{{item.name}}会员




